GNI GroupGNIIF 82 Days Inventory is 241.27 as of Mar. 2026, which is 6% above its 10-year median of 228.13. GuruFocus rates GNIIF with a GF Score™ of 82/100 and a GF Value™ of $17.11. The stock has 5 warning signs investors should review. Among 638 Biotechnology companies, GNI Group ranks worse than 50.16% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). GNI Group's Average Total Inventories for the
three
months ended in Mar. 2026 was $25.0 Mil. GNI Group's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $9.5 Mil.
Hence, GNI Group's Days Inventory for the
three
months ended in Mar. 2026 was 241.27.
The historical rank and industry rank for GNI Group's Days Inventory or its related term are showing as below:
GNIIF'
s Days Inventory Range Over the Past 10 Years
Min: 155.4 Med: 228.13 Max: 419.19
Current: 183.97
During the past 13 years, GNI Group's highest Days Inventory was 419.19. The lowest was 155.40. And the median was 228.13.
GNIIF's Days Inventory is ranked worse than 50.16% of 638
companies
in the Biotechnology industry
Industry Median: 183.875
vs GNIIF: 183.97
GNI Group's Days Inventory
increased
from Mar. 2025 (204.29) to Mar. 2026 (241.27).
It might indicate that GNI Group's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
GNI Group's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.38.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
GNI Group's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.72.
GNI Group (OTCPK:GNIIF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
GNI Group's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
GNI Group's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
GNI Group Days Inventory Related Terms
GNI Group Days Inventory Historical Data
* Premium members only.
The historical data trend for GNI Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GNIIF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, GNI Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GNI Group Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GNI Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where GNI Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GNI Group (GNIIF) has a Days Inventory of 241.27 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on GNI Group and its competitors. This is near median its historical median of 228.13. Over the past decade, GNI Group's Days Inventory has ranged from 155.40 to 419.19. According to the industry distribution chart, GNI Group ranks #320 out of 638 companies in the Biotechnology industry, placing it in the top 50.2%.
Is GNI Group's Days Inventory too high?
GNI Group's current Days Inventory of 241.27 is near median its 10-year median of 228.13. Over the past 10 years, this metric has ranged from a low of 155.40 to a high of 419.19. The Biotechnology industry median Days Inventory is 183.88. GNI Group's value of 241.27 is 31.2% above this industry median. Based on the distribution chart, GNI Group ranks #320 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, GNI Group has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does GNI Group's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, GNI Group ranks #320 out of 638 companies for Days Inventory. This places GNI Group in the lower half of its industry. The industry median Days Inventory is 183.88. GNI Group's value of 241.27 is 31.2% above this benchmark. Historically, GNI Group's own Days Inventory has ranged from 155.40 to 419.19 over the past decade. While the company's 10-year median is 228.13 vs. the industry median of 183.88, GNI Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GNI Group's current Days Inventory of 241.27 is 31.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on GNI Group and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GNI Group's current Days Inventory is 241.27, which is near median its own 10-year median of 228.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GNI Group stock overvalued right now?
GNI Group (GNIIF) has a current Days Inventory of 241.27. The stock's GF Value™ is $17.11, compared to a current price of $15.50 — trading 9.4% below its estimated fair value. The current Days Inventory is 241.27, which is near median its 10-year median of 228.13 and 31.2% above the Biotechnology industry median of 183.88. GNI Group's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For GNI Group (GNIIF), the current Days Inventory is 241.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GNI Group (GNIIF) Overvalued in 2026?
Based on GuruFocus' analysis, GNI Group stock appears to be undervalued.
The current stock price of $15.50 is trading 9.4% below its estimated GF Value™ of $17.11.
Key valuation signals for GNIIF:
Days Inventory: 241.27 (near median its 10-year median of 228.13)
GF Value™: $17.11 vs. price of $15.50 (9.4% below fair value)
Industry Position: 31.2% above the Biotechnology median (#320 of 638)
No single metric tells the full story. See the GNIIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
82GF Score
Get the complete analysis for GNIIF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GNIIF has been successfully added to your 
